This issue provides key information on influenza vaccines and antiviral medications for the 2018-2019 flu season, including precautions, side effects, and use in special populations. Influenza (commonly referred to as “the flu”) is a contagious viral...read more
I’ve heard about new blood thinning medications I could take instead of Coumadin® (warfarin). Should I change my treatment?
There are 5 newer blood thinning medications on the market for the treatment and/or prevention of blood clots, and for the prevention of stroke in patients with atrial fibrillation (A-fib). They are known as DOACs. In general, DOACs work as well or better...read more
[HPV] 9-valent vaccine), which protects against 9 HPV strains, is most effective when administered before sexual activity begins; it is a recommended vaccine for 9 through 26 year olds. The FDA recently approved expanding the age range to women and men 27...read more
In-depth analysis confirms sharp increases, geographic spread of synthetic opioid-related deaths Centers for Disease Control and Prevention Press Release For Immediate Release: Friday, December 21, 2018 Contact: Media Relations (404) 639-3286 U.S. overdose...read more
Heartburn is a burning sensation in the chest that may radiate toward the neck, throat, and occasionally, the back. It most often results from the reflux of gastric contents into the esophagus. Heartburn is among the most common gastrointestinal...read more
Many people fear that taking opioids will lead toaddiction. This fear often leads to not taking the medicationor not taking the right amount, which can causeneedless suffering. Addiction, which involves a powerfulcraving for – or psychological need for – a...read more
The FDA has approved a directto- consumer test that assesses genetic variations that may affect a person’s ability to metabolize certain drugs. The manufacturer, 23andMe, has reported that the test can detect 33 variants for multiple genes, which may...read more
This issue will review the evidence supporting DOACs and their place in therapy for: 1) atrial fibrillation (AF); 2) the acute treatment and long-term secondary prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE); and 3) DVT and PE...read more
Migraines affect 10% of the population - with women affected 3 times more than men. A first in class biologic, erenumab (Aimovig®), has been approved for migraine prevention. Erenumab is a monoclonal antibiody that binds to and blocks calcitonin...read more
Sodium glucose co-transporter 2 (SGLT2) inhibitors are a relatively new class of drugs recommended for people with type 2 diabetes whose blood sugar numbers are too high. The available medications are canagliflozin (Invokana™), dapagliflozin...read more
About The Rx Consultant
The Rx Consultant is a subscription-based service that delivers practical updates, continuing education & reviews covering all the top-selling drugs and common health conditions. All our publications focus on the facts busy front-line pharmacists, nurse practitioners and pharmacy technicians need to stay current.
Each issue contains a drug therapy update with CE, patient Q&A, healthcare news, charts & tables and quick facts cards. The Continuing Education Network is an ACPE approved provider - credit for pharmacists is automatically reported to CPE Monitor. Our CE meets ANCC & AANP criteria, allowing nurse practitioners to fulfill their pharmacology CE needs.
The Rx Consultant has subscribers throughout the United States, Canada & The UK.